NC8, Inc.赞助的临床试验
总计49093个结果
-
OSI PharmaceuticalsNational Cancer Institute (NCI)完全的
-
Zenalux Biomedical, Inc.National Cancer Institute (NCI); Duke University未知
-
Klein Buendel, Inc.National Cancer Institute (NCI); Kaiser Permanente主动,不招人
-
Northwestern UniversityNational Cancer Institute (NCI); Vasgene Therapeutics, Inc主动,不招人进行性疾病 | 去势抵抗性前列腺癌 | IVB 期前列腺癌 AJCC v8 | PSA 进展 | 转移性前列腺癌 | 睾酮的去势水平 | 前列腺癌骨转移 | 对第二代雄激素受体轴靶向药物无效的去势抵抗性前列腺癌 | 软组织转移性前列腺癌 | 睾酮低于 50 ng/dL美国
-
Hamilton Health Sciences CorporationMcMaster University; AllerGen NCE Inc.完全的
-
OncoImmune, Inc.National Cancer Institute (NCI); Huntsman Cancer Institute撤销
-
Northwestern UniversityNational Cancer Institute (NCI); Moleculin Biotech, Inc.尚未招聘
-
Massachusetts General HospitalNational Cancer Institute (NCI); Genentech, Inc.未知
-
Duke UniversityAlkermes, Inc.; Laura and John Arnold Foundation; FHR (Fellowship Health Resources, Inc.); Drug...完全的
-
OBELAB, Inc.Helptrial Inc.尚未招聘
-
89bio, Inc.ProSciento, Inc.完全的
-
Eisai Inc.Quintiles, Inc.终止
-
Eisai Inc.Quintiles, Inc.终止
-
Seagen Inc.Genentech, Inc.完全的淋巴瘤,大 B 细胞,弥漫性 | 淋巴瘤,非霍奇金美国
-
Seagen Inc.Genentech, Inc.完全的
-
Pamlab, Inc.InfoMedics, Inc.完全的
-
Emory UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; Astellas Pharma Inc; Seagen Inc.招聘中III 期膀胱癌 AJCC v8 | IV 期膀胱癌 AJCC v8 | 膀胱腺癌 | 膀胱鳞状细胞癌 | 转移性膀胱癌 | 脐尿管腺癌 | 局部晚期膀胱癌 | 恶性肾盂肿瘤 | 恶性输尿管肿瘤 | 恶性尿道肿瘤 | 不可切除的膀胱癌美国
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Astellas Pharma Inc; OSI Pharmaceuticals完全的
-
Astellas Pharma IncSeagen Inc.; Agensys, Inc.完全的
-
Mylan Technologies Inc.Mylan Inc.主动,不招人
-
AngioSafe, Inc.Veranex, Inc.招聘中
-
Xoft, Inc.Icad, Inc.终止